|
|
2004-present
The reports that feature these Executive Summaries are published and available for immediate shipment.
Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
July 2008
Systems Biology: A Disruptive Technology
May 2008
Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
May 2008
Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008
Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
April 2008
MicroRNAs: Commercial Products on the Horizon
March 2008
Epigenetics: Technologies, Applications, and the Commercial Landscape
February 2008
Multiplex Assays in Translational Medicine: Technologies, Applications, and Future Directions
February 2008
Molecular Imaging in Drug R&D and Medical Practice
January 2008
Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets
January 2008
Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
December 2007
Molecular Diagnostics: A Rapidly Shifting Commercial and Technology Landscape
November 2007
Monoclonal Antibodies: Pipeline Analysis and Market Assessment
October 2007
Backup Compound Strategies: Best Practices for Reducing Phase II Risk
September 2007
Adaptive Clinical Trials: Innovation in Trial Design, Management, and Analysis
September 2007
Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
August 2007
Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes
July 2007
Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
June 2007
Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
May 2007
High-Content Analysis: Technologies, Applications, Market Analysis
May 2007
Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
May 2007
Metabolic and Inflammatory Disease R&D : An Assessment of 5 Highly Promising Therapeutic Classes
April 2007
|